These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38011024)

  • 21. Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.
    Roch B; Coffy A; Jean-Baptiste S; Palaysi E; Daures JP; Pujol JL; Bommart S
    Lung Cancer; 2020 May; 143():19-26. PubMed ID: 32200137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
    Liu Q; Medina HN; Rodriguez E; Jacobs KT; Brown C; Koru-Sengul T; Lopes G; Pinheiro PS
    Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):489-499. PubMed ID: 38252069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
    Phillips I; Sandhu S; Lüchtenborg M; Harden S
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia.
    Nguyen AD; Wong W; Beydoun N; Mohan S; Shafiq J; Vinod SK
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):131-141. PubMed ID: 30281917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years).
    Aridgides PD; Janik A; Bogart JA; Duffy S; Rosenbaum P; Gajra A
    Clin Lung Cancer; 2013 Nov; 14(6):674-9. PubMed ID: 23891240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors.
    Murata D; Azuma K; Matsuo N; Murotani K; Matama G; Kawahara A; Sasada T; Tokito T; Hoshino T
    Cancer Med; 2023 Oct; 12(19):19471-19479. PubMed ID: 37712645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.
    Chen LM; Ignacio L; Jacobs R; Kozloff M; Telfer M; Elahi R; Evans R; Vijayakumar S
    Radiat Oncol Investig; 1999; 7(1):49-53. PubMed ID: 10030624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
    LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
    J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
    Stevens R; Macbeth F; Toy E; Coles B; Lester JF
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
    Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
    Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.
    Mytelka DS; Li L; Benoit K
    J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):86-92. PubMed ID: 29205930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease.
    Kim H; Hwang J; Kim SM; Choi J; Yang DS
    BMC Cancer; 2023 Oct; 23(1):992. PubMed ID: 37848850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
    Sampath S; Hall M; Schultheiss TE
    Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Chemoradiotherapy-induced Weight Loss Decreases Survival in Locally Advanced Non-small Cell Lung Cancer Patients.
    Kim YJ; Song C; Eom KY; Kim IA; Kim JS
    In Vivo; 2019; 33(3):955-961. PubMed ID: 31028222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy.
    Burtin C; Bezuidenhout J; Sanders KJC; Dingemans AC; Schols AMWJ; Peeters STH; Spruit MA; De Ruysscher DKM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):424-431. PubMed ID: 32045108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
    Meldgaard P; Kristensen M; Conte S; Kaae Andersen K; Jovanovic A; Meldgaard E
    Acta Oncol; 2023 Dec; 62(12):1672-1679. PubMed ID: 37699061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks.
    van der Meij BS; Schoonbeek CP; Smit EF; Muscaritoli M; van Leeuwen PA; Langius JA
    Br J Nutr; 2013 Jun; 109(12):2231-9. PubMed ID: 23153477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized clinical trial of adenosine 5'-triphosphate on tumor growth and survival in advanced lung cancer patients.
    Agteresch HJ; Burgers SA; van der Gaast A; Wilson JH; Dagnelie PC
    Anticancer Drugs; 2003 Sep; 14(8):639-44. PubMed ID: 14501386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.